Medifast Statistics
Total Valuation
Medifast has a market cap or net worth of $203.87 million. The enterprise value is $68.01 million.
| Market Cap | 203.87M |
| Enterprise Value | 68.01M |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, after market close.
| Earnings Date | Aug 5, 2024 |
| Ex-Dividend Date | Sep 18, 2023 |
Share Statistics
Medifast has 10.94 million shares outstanding. The number of shares has increased by 0.54% in one year.
| Shares Outstanding | 10.94M |
| Shares Change (YoY) | +0.54% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 2.55% |
| Owned by Institutions (%) | 105.08% |
| Float | 9.64M |
Valuation Ratios
The trailing PE ratio is 3.01 and the forward PE ratio is 34.50. Medifast's PEG ratio is 1.95.
| PE Ratio | 3.01 |
| Forward PE | 34.50 |
| PS Ratio | 0.23 |
| Forward PS | 0.31 |
| PB Ratio | 0.97 |
| P/FCF Ratio | 2.41 |
| PEG Ratio | 1.95 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 0.67, with an EV/FCF ratio of 0.80.
| EV / Earnings | 1.00 |
| EV / Sales | 0.08 |
| EV / EBITDA | 0.67 |
| EV / EBIT | 0.82 |
| EV / FCF | 0.80 |
Financial Position
The company has a current ratio of 2.85, with a Debt / Equity ratio of 0.10.
| Current Ratio | 2.85 |
| Quick Ratio | n/a |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.20 |
| Debt / FCF | 0.24 |
| Interest Coverage | -21.36 |
Financial Efficiency
Return on equity (ROE) is 34.30% and return on invested capital (ROIC) is 27.18%.
| Return on Equity (ROE) | 34.30% |
| Return on Assets (ROA) | 21.70% |
| Return on Capital (ROIC) | 27.18% |
| Revenue Per Employee | $1.42M |
| Profits Per Employee | $106,880 |
| Employee Count | 634 |
| Asset Turnover | 2.87 |
| Inventory Turnover | 3.37 |
Taxes
In the past 12 months, Medifast has paid $19.29 million in taxes.
| Income Tax | 19.29M |
| Effective Tax Rate | 22.16% |
Stock Price Statistics
The stock price has decreased by -80.20% in the last 52 weeks. The beta is 1.18, so Medifast's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -80.20% |
| 50-Day Moving Average | 21.84 |
| 200-Day Moving Average | 46.08 |
| Relative Strength Index (RSI) | 38.35 |
| Average Volume (20 Days) | 691,335 |
Short Selling Information
The latest short interest is 2.94 million, so 26.88% of the outstanding shares have been sold short.
| Short Interest | 2.94M |
| Short Previous Month | 3.44M |
| Short % of Shares Out | 26.88% |
| Short % of Float | 30.50% |
| Short Ratio (days to cover) | 3.52 |
Income Statement
In the last 12 months, Medifast had revenue of $897.81 million and earned $67.76 million in profits. Earnings per share was $6.20.
| Revenue | 897.81M |
| Gross Profit | 656.75M |
| Operating Income | 80.83M |
| Pretax Income | 87.05M |
| Net Income | 67.76M |
| EBITDA | 100.90M |
| EBIT | 83.16M |
| Earnings Per Share (EPS) | $6.20 |
Balance Sheet
The company has $156.43 million in cash and $20.57 million in debt, giving a net cash position of $135.86 million or $12.42 per share.
| Cash & Cash Equivalents | 156.43M |
| Total Debt | 20.57M |
| Net Cash | 135.86M |
| Net Cash Per Share | $12.42 |
| Equity (Book Value) | 210.96M |
| Book Value Per Share | 19.29 |
| Working Capital | 142.40M |
Cash Flow
In the last 12 months, operating cash flow was $90.88 million and capital expenditures -$6.21 million, giving a free cash flow of $84.67 million.
| Operating Cash Flow | 90.88M |
| Capital Expenditures | -6.21M |
| Free Cash Flow | 84.67M |
| FCF Per Share | $7.76 |
Margins
Gross margin is 73.15%, with operating and profit margins of 9.00% and 7.55%.
| Gross Margin | 73.15% |
| Operating Margin | 9.00% |
| Pretax Margin | 9.70% |
| Profit Margin | 7.55% |
| EBITDA Margin | 11.24% |
| EBIT Margin | 9.26% |
| FCF Margin | 9.43% |
Dividends & Yields
This stock pays an annual dividend of $1.65, which amounts to a dividend yield of 8.85%.
| Dividend Per Share | $1.65 |
| Dividend Yield | 8.85% |
| Dividend Growth (YoY) | 3.94% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 26.61% |
| Buyback Yield | -0.54% |
| Shareholder Yield | 8.31% |
| Earnings Yield | 33.24% |
| FCF Yield | 41.53% |
Analyst Forecast
The average price target for Medifast is $49.75, which is 166.90% higher than the current price. The consensus rating is "Sell".
| Price Target | $49.75 |
| Price Target Difference | 166.90% |
| Analyst Consensus | Sell |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medifast has an Altman Z-Score of 6.61 and a Piotroski F-Score of 7.
| Altman Z-Score | 6.61 |
| Piotroski F-Score | 7 |